BillionToOne shares jump as much as 100% in stunning Nasdaq debut

BillionToOne

06/11/2025 18:48

Updates

** Molecular diagnostics firm BillionToOne's BLLN.O shares jump as much as 100% in their Nasdaq debut

** Stock opened at $100 apiece and jumped as high as $120; last up 93.6% at $116.15

** BLLN sold 4.56 million shares in an upsized IPO at $60 apiece to raise $273.1 million

** Menlo Park, California-based BLLN had initially marketed 3.85 million shares between $49 and $55 apiece

** BLLN develops molecular diagnostic tests — including a non-invasive prenatal screen and liquid biopsy — for various diseases

** In the six months ended June 30, BLLN's revenue surged 82% to $125.5 million, while net loss narrowed to $4.2 million

** J.P. Morgan, Piper Sandler, Jefferies and William Blair were joint book-running managers for the offering

 (Reporting by Arasu Kannagi Basil in Bengaluru)

 ((ArasuKannagi.Basil@thomsonreuters.com))